http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011218817-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de09168142c4f96ceeaad5942598ecdf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-20
filingDate 2009-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa922902ed210f55219dedba2a2a475b
publicationDate 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011218817-A1
titleOfInvention Method for carrying out clinical studies and method for establishing a prognosis model for clinical studies
abstract A method for planning and carrying out clinical studies, wherein, during and after the end of a predetermined period, values of a predefined target criterion of control persons of a virtual control group are compared with values of the predefined target criterion of test persons of a test group which received a treatment to be investigated. The values of the predefined target criterion of the control persons of the virtual control group during and after the end of the predetermined period are determined from starting characteristics values assigned to the control persons.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016140322-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021057108-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113436140-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11636309-B2
priorityDate 2008-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57339251

Total number of triples: 18.